An independent study has shown that Life Whisperer Genetics, a non-invasive and instant AI-based embryo assessment, is effective in predicting whether an embryo is likely to lead to a live birth or miscarriage. The study was presented at the American Society for Reproductive Medicine (ASRM) 2023 in New Orleans by Carla Giménez-Rodríguez from IVI-RMA in Europe. IVI-RMA comprises over 70 fertility centers across 9 countries.
Life Whisperer uses Artificial Intelligence to non-invasively and instantly assess images of embryos to evaluate their quality in order to improve IVF outcomes. Life Whisperer Genetics non-invasively assesses images of embryos to determine their likelihood of being euploid (chromosomally normal), using only morphology. The AI assessment can be used to rank and prioritize good quality embryos based on euploidy, for further testing or for transfer.
The study tested Life Whisperer Genetics on 507 embryos, and showed that there were significant differences between the AI scores for embryos that led to a live birth, compared to those that did not, and between embryos that led to a miscarriage and those that did not. Therefore, the AI algorithm was able to distinguish those embryos with a higher likelihood of leading to a live birth and those that are likely to result in miscarriage.
Additionally, compared with manual embryo grading by embryologists, the AI algorithm showed a 9% reduction in time to pregnancy, a 19% reduction in time to live birth, a 14% relative improvement in first cycle pregnancy rate, and a 37% relative improvement in first cycle live birth rate.
The study concluded that the use of predictive models on embryo images may help embryologists to make decisions on which embryos to prioritize for transfer.
Following the recent launch of Life Whisperer Genetics into the United States, the study provides further evidence of the efficacy of non-invasive and instant AI methods for ranking good quality embryos, whether prioritizing embryos for further PGT-A testing or for transfer.
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.